Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cardlytics, Inc. Director's Dealing 2020

May 20, 2020

33956_dirs_2020-05-20_8355946f-81fd-498c-9180-49851138342d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-05-19

Reporting Person: Grimes Scott D. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-19 Common Stock S 2000 $60 Disposed 129112 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 214431 Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.

F2: The reportable securities are held by the GRAT.